MEDRAD has signed a distribution and co-marketing partnership agreement with PETNet Solutions, a fully owned subsidiary of Siemens Medical Solutions USA.
The agreement will allow healthcare providers to inject fluorodeoxyglucose (FDG) for PET/CT imaging procedures in a new way, according to Warrendale, Pa.-based MEDRAD.
The partnership will leverage MEDRAD’s soon-to-be introduced PET infusion system and multi-dose FDG packaging and delivery from PETNet, the company said.
The company said its PET infusion system, to be called Intego, is designed to automatically extract a patient dose from a multi-dose vial and deliver it directly to the patient. The system is mobile and includes dosimetry, shielding and a touchscreen interface.